Mairuike Bio

麦锐克

Mairuike Bio

Biotech/Healthcare

Mairuike Biotech, founded in 2022, was established and is led by a US-trained PhD returnee. The company has assembled a team of high-level R&D personnel in biomedical research from China and abroad, and has built its proprietary innovation platform on core microRNA technology.

Latest round: Angel (2024)

Source: ChinaBulls — chinabulls.com

Last updated 2024-01-01

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.